Celebrating its sixth program, McDermott+Consulting’s +Dx Diagnostics Forum is the premier annual program for the laboratory diagnostics community.

Join us, virtually, for a comprehensive discussion and analysis of pertinent regulatory and reimbursement issues that focus on the laboratory diagnostics field’s transformative nature.

Gain insight into how the industry addresses regulatory and business challenges and embraces new and exciting technology in an ever-evolving health policy landscape. New this year, a unique partnering experience to connect with key players in the industry.

Industry innovators, lawmakers and leading regulators will provide in-depth analysis, thoughtful guidance and strategic insights on:

• Local and national coverage for the molecular testing marketplace, featuring both Centers for Medicare & Medicaid Services (CMS) leadership and Medicare Administrative Contractors (MACs) from MolDX and Novitas
• Food and Drug Administration (FDA) oversight of diagnostic testing, including laboratory-developed tests
• Fraud and abuse trends in diagnostic testing arrangements
• Private payer positioning and evidence for diagnostic testing
• The new administration’s focus on the scientific and research community to accelerate vaccines, therapies and diagnostics